• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Novocure says data exposed in cybersecurity incident

Novocure says data exposed in cybersecurity incident

September 4, 2026 By Chris Newmarker

This is the logo of Novocure.Tumor treating fields (TTFields) developer Novocure disclosed this week that a recent cybersecurity incident exposed patient and employee information.

According to an SEC Form 8-K dated Sept. 1, Novocure, through a subsidiary, became aware of unauthorized access to some of its information systems in mid-August. In response, it implemented containment measures, launched an internal investigation, and engaged independent cybersecurity forensic experts.

Baar, Switzerland–based Novocure says exposed data included:

  • Internal company patient ID numbers for over 1,400 U.S. patient records (The company says the ID numbers are only used internally and no patient names or other identifying data for these was exposed);
  • Patient data for fewer than 50 other patients in the western U.S. that included additional identifying information;
  • General contact information for healthcare providers that work with the company;
  • General contact information for Novocure employees, such as their job titles and phone numbers.

According to Novocure, no access to any medical treatment devices was obtained, no compromise of operations occurred, and there was no effect on company systems.

Novocure said in the SEC form: “The company takes its obligation to safeguard privacy and security of its patients’ data very seriously. The company continues to evaluate applicable regulatory and legal notification requirements and will make all required notifications based on its findings, including to impacted patients. At this time, we do not believe that this cybersecurity incident will have a material impact or reasonably likely material impact on our financial condition and results of operations; however, at the time of this filing we are continuing to ascertain additional information regarding this incident.”

Novocure media relations could not be immediately reached for comment.

The Novocure data breach is the latest in a string of cybersecurity incidents that medical device companies have disclosed this year. Last week, news broke of a cybersecurity incident that caused a global network communications outage at Boston Scientific. Earlier this year, an Iran-backed cyberattack effectively wiped out data on Stryker’s Microsoft-based IT system. Medtronic, Intuitive, and iRhythm have also reported cybersecurity incidents.

Filed Under: Business/Financial News, Featured, Oncology Tagged With: Cybersecurity, NovoCure

More recent news

  • Perfuze’s super-bore stroke catheter tops conventional, cyclic aspiration in bench study
  • Edwards Lifesciences taps GE HealthCare vet to head new digital engineering group
  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • GE HealthCare taps retiring AT&T CFO for board of directors
  • Corcym delivers first-in-human implant of Memo 4D Curve mitral repair ring

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy